Ready to submit? Start a new submission or continue a submission in progress

Go to submission site (link opens in a new window)

Journal overview

Leukemia & Lymphoma is an international peer reviewed journal that publishes research on all aspects of hematological malignancies.

The journal aims to address the needs of physicians and scientists interested in clinical, translational, laboratory and basic science research, as well as clinical diagnosis and treatment of patients with malignant hematological disorders.

Leukemia & Lymphoma covers from clinical and clinico-pathological investigations to fundamental research in the following topics:

  • disease biology
  • mechanisms of action of novel agents
  • development of combination chemotherapy
  • pharmacology and pharmacogenomics
  • ethics and epidemiology

Submissions of unique clinical observations or confirmatory studies are considered and published as Letters to the Editor.

The journal accepts original articles (clinical and research), review articles, letters to the editor, correspondence, commentaries, emerging drug profiles, clinical dilemmas.

The journal operates a double-anonymized peer review policy.
Authors can choose to publish gold open access in this journal.
Read the Instructions for Authors for information on how to submit your article.

Read full aims and scope

Explore articles

Explore the most recently published articles

Christina von Roemeling et al.
Review Article |
Open Access
Jessica M. Stempel et al.
Review Article |

Latest issues

Advertise in this journal

Reach an engaged target audience and position your brand alongside authoritative peer-reviewed research by advertising in Leukemia & Lymphoma.

Explore advertising options